← Back to Search

Breathing Techniques + Meditation for COVID-19 Stress Management

Phase 1

Waitlist Available

Led By Santhosshi Narayanan

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must not have

Brain bleeding in the past 1 year

Brain tumor

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 2 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will investigate whether breathing techniques and meditation can help reduce stress and improve lung health for healthcare workers during the COVID-19 pandemic.

Who is the study for?

This trial is for health care workers at MD Anderson Cancer Center who can read and understand English. It's not suitable for those with recent abdominal surgery not cleared for exercise, brain aneurysm or tumor, history of brain bleeding within the last year, epilepsy, or if pregnant.

What is being tested?

The study explores whether breathing techniques and meditation can reduce stress and improve lung health in healthcare workers during the COVID-19 pandemic. Participants will engage in yoga, complete questionnaires, undergo quality-of-life assessments, and follow a media intervention.

What are the potential side effects?

Since this trial involves non-invasive practices like meditation and yoga rather than medication or medical procedures, significant side effects are unlikely. However, participants may experience mild discomfort from new physical activities.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have not had brain bleeding in the last year.

Select...

I have a brain tumor.

Select...

I have a brain aneurysm.

Select...

I have epilepsy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of Participants Recruited to the Study (Feasibility)

Number of Participants Who Perceived the Intervention as Useful

Secondary study objectives

Adherence to the Practice

Breath Holding Time

Change in Resilience

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive Care (video, breathing techniques, meditation)Experimental Treatment5 Interventions

Patients view an instructional video on breathing techniques and meditation. Patients then perform breathing techniques over 3 minutes and meditation over 2 minutes BID for 28 days.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Yoga

2008

Completed Phase 3

~3830

Meditation Therapy

2018

N/A

~50